ArTS Archivio della ricerca di Trieste

TEDESCO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.931
EU - Europa 18.272
AS - Asia 15.542
SA - Sud America 5.073
AF - Africa 628
OC - Oceania 403
Continente sconosciuto - Info sul continente non disponibili 325
Totale 68.174
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.688
CN - Cina 5.479
IT - Italia 4.855
BR - Brasile 2.995
DE - Germania 2.045
SG - Singapore 1.845
ES - Italia 1.580
GB - Regno Unito 1.313
MX - Messico 1.299
PL - Polonia 1.242
JP - Giappone 1.191
IN - India 1.082
FR - Francia 1.061
TR - Turchia 1.010
SE - Svezia 959
HK - Hong Kong 778
ID - Indonesia 773
UA - Ucraina 702
CA - Canada 691
VN - Vietnam 665
NL - Olanda 557
KR - Corea 531
RU - Federazione Russa 518
CO - Colombia 485
PT - Portogallo 474
AR - Argentina 466
TW - Taiwan 452
FI - Finlandia 444
PE - Perù 390
GR - Grecia 353
CL - Cile 346
AU - Australia 334
AT - Austria 268
TH - Thailandia 261
CH - Svizzera 253
BE - Belgio 237
EC - Ecuador 217
IE - Irlanda 207
RO - Romania 199
SA - Arabia Saudita 196
DK - Danimarca 167
PK - Pakistan 161
EG - Egitto 146
IR - Iran 141
BG - Bulgaria 137
BD - Bangladesh 123
CZ - Repubblica Ceca 118
IL - Israele 116
MY - Malesia 101
MA - Marocco 99
PH - Filippine 96
HU - Ungheria 91
ZA - Sudafrica 89
IQ - Iraq 78
HR - Croazia 75
SI - Slovenia 69
RS - Serbia 67
NZ - Nuova Zelanda 66
TN - Tunisia 61
VE - Venezuela 61
LB - Libano 53
LT - Lituania 53
PA - Panama 52
NO - Norvegia 50
LV - Lettonia 47
AE - Emirati Arabi Uniti 41
BO - Bolivia 39
CR - Costa Rica 39
GT - Guatemala 38
JO - Giordania 38
KZ - Kazakistan 36
NG - Nigeria 36
UY - Uruguay 36
SK - Slovacchia (Repubblica Slovacca) 35
DZ - Algeria 34
UZ - Uzbekistan 31
PY - Paraguay 30
NP - Nepal 28
QA - Qatar 27
HN - Honduras 26
LK - Sri Lanka 26
PS - Palestinian Territory 23
SY - Repubblica araba siriana 21
OM - Oman 20
SN - Senegal 20
BY - Bielorussia 19
GE - Georgia 19
NI - Nicaragua 19
CY - Cipro 18
EE - Estonia 18
KE - Kenya 17
DO - Repubblica Dominicana 16
ET - Etiopia 16
AZ - Azerbaigian 15
SV - El Salvador 13
KW - Kuwait 12
PR - Porto Rico 12
BA - Bosnia-Erzegovina 11
LU - Lussemburgo 11
RE - Reunion 11
Totale 67.609
Salva come PNG Salva come JPEG
Città #
Ashburn 9.317
Fairfield 1.260
Woodbridge 1.179
Singapore 1.171
Ann Arbor 1.039
Germantown 1.013
Houston 915
Warsaw 788
Milan 631
Chandler 625
Beijing 615
San Jose 603
Jacksonville 594
Seattle 587
Wilmington 571
Rome 547
São Paulo 513
Dallas 501
Hong Kong 481
Munich 468
Cambridge 434
Trieste 422
Madrid 406
Shanghai 365
Guangzhou 341
Los Angeles 327
Tokyo 323
Istanbul 304
Chicago 285
New York 282
Seoul 280
Hefei 264
Lima 251
Rio de Janeiro 250
Barcelona 247
Paris 240
Council Bluffs 235
Princeton 230
Ho Chi Minh City 221
Santa Clara 221
Frankfurt am Main 214
Bogotá 210
Hangzhou 203
Hanoi 192
Athens 185
Helsinki 185
Buenos Aires 184
Dublin 184
Columbus 183
Santiago 181
Taipei 181
Boardman 174
Jakarta 171
Lisbon 169
Izmir 168
Moscow 167
Vienna 157
Ankara 156
Naples 155
Montréal 151
Chengdu 146
Mcallen 143
Bangkok 139
Turin 139
Bologna 136
Bengaluru 133
The Dalles 129
Amsterdam 127
Florence 126
London 123
Sofia 121
Curitiba 115
Nanjing 115
Boston 114
Brasília 110
Berlin 106
Mumbai 104
Medellín 103
Toronto 103
Chennai 102
Hyderabad 102
Melbourne 100
Zurich 100
Las Vegas 99
Washington 99
Buffalo 98
Valencia 97
Zgierz 96
Lauterbourg 94
Montreal 93
Wuhan 93
San Diego 92
Quito 90
Sydney 90
Belo Horizonte 89
Guadalajara 89
Porto Alegre 89
Copenhagen 88
Thessaloniki 88
Verona 88
Totale 37.224
Salva come PNG Salva come JPEG
Nome #
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 44.816
Pathogenic role of complement in antiphospholipid syndrome and therapeutic implications 778
Targeted delivery of neutralizing anti-C5 antibody to renal endothelium prevents complement- dependent tissue damage 419
Complement Protein C1q binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumour Growth 410
C1q as a novel player in angiogenesis with therapeutic implication in wound healing 372
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis 348
A non-complement-fixing antibody to  2 glycoprotein I as a novel therapy for antiphospholipid syndrome 343
C1q is involved in human trophoblast invasion 329
New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats 329
C1q secreted in the tumour microenvironment promotes tumour growth in the absence of complement activation 324
Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats. 322
Complement as a biological tool to control tumor growth 320
C1q is associated with a reduced inflammatory response of decidual endothelial cells 308
Pre-eclampsia is associated with defective production of C1q by invasive trophoblast 296
C1q: A novel angiogenic factor? 292
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies. 290
Targeted nanoparticles and complement activation 285
Innate immunity, through late complement components activation, contributes to the development of early vascular inflammation and morphologic alterations in experimental diabetes. 279
Critical role and therapeutic control of the lectin pathway of complement activation in an abortion-prone mouse mating 262
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia 262
An insight into normal and pathological pregnancies using large-scale microarrays: lessons from microarrays. 261
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo. 258
Chemerin Regulates NK Cell Accumulation and Endothelial Cell Morphogenesis in the Decidua during Early Pregnancy 257
Bilirubin inhibits the TNFα-related induction of three endothelial adhesion molecules 251
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 240
Placental trophoblast and endothelial cells as target of maternal immune response. 239
In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab. 234
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. 233
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5 231
Bactericidal activities of human polymorphonuclear leukocyte proteins against Escherichia coli 0111:B4 coated with C5 or C8 229
Complement as effector system in cancer immunotherapy. 227
Complement C1q and C8beta deficiency in an individual with recurrent bacterial meningitis and adult-onset systemic lupus erythematosus-like illness. 226
Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma. 220
The seventh complement component is expressed on endothelial cells membrane and exerts an anti-inflammatory action 218
Bilirubin inhibits the TNFalpha-related induction of three endothelial adhesion molecules. 216
Preeclampsia is associated with defective production of C1q by invasive trophoblast 206
Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo 204
OP0023 Targeted Polymeric Nanoparticles as Diagnostic and Therapeutic Tool for Rheumatoid Arthritis 201
The neutrophil-activating protein of Helicobacter pylori crosses endothelia to promote neutrophil adhesion in vivo. 200
Dynamics of complement activation in aHUS and how to monitor eculizumab therapy 200
Chacterization of soluble terminal complement complex assembled in C8ß-deficient plasma and serum 199
Biological response of B lymphoma cells to anti-CD20 monoclonal antibody Rituximab in vitro: CD55 and CD59 regulate complement mediated lysis. 199
The terminal complement complex induces vascular leakage: in vitro and in vivo evidence 199
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. 195
Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 194
MBL interferes with endovascular trophoblast invasion in pre-eclampsia. 194
Complement in human diseases: Lessons from complement deficiencies. 193
Analysis of the molecular mechanisms of C1-inhibitor deficiency induced angioedema 193
Inherited complement deficiencies and bacterial infections. 191
Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina 190
C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function. 189
Complement activation in animal and human pregnancies as a model for immunological recognition 188
Exploratory study on the effects of biodegradable nanoparticles with drugs on malignant B cells and on a human/mouse model of Burkitt lymphoma. 181
Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex. 177
The Complement System at the Embryo Implantation Site: Friend or Foe? 175
C1q induces in vivo angiogenesis and promotes wound healing 173
P-selectin glycoprotein ligand-1 as a potential target for humoral immunotherapy of multiple myeloma. 171
The C7 component of the complement system localizes to vascular smooth muscle cells and endothelium in human first trimester decidua 171
FRI0030 Anti-TNF-α Antibody Targeted To Inflamed Synovial Tissue for The Treatment of Rheumatoid Arthritis 171
The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis. 170
Cross-talk between the complement and the kinin system in vascular permeability 170
An elctrophysiological study of the effects of myasthenia gravis sera and complement on rat isolated muscle fibres. 169
Posttransplant ischemia-reperfusion injury in transplanted heart is prevented by a minibody to the fifth component of complement. 167
Serum-Resistant Strains of Borrelia burgdorferi Evade Complement-Mediated Killing by Expressing a CD59-Like Complement Inhibitory Molecule 166
Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity. 166
An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development. 166
Humoral immunotherapy of multiple myeloma: perspectives and perplexities. 165
Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. 161
VE-cadherin is a critical molecule for trophoblast-endothelial cell interaction in decidual spiral arteries. 161
In vivo biodistribution and lifetime analysis of cy5.5-conjugated rituximab in mice bearing lymphoid tumor xenograft using time-domain near-infrared optical imaging. 160
Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflammation. 159
null 159
Hepatocyte nuclear factor 1a controls the expression of terminal complement genes 157
null 155
Role of the B1 Bradykinin Receptor and gC1qR/p33 in Angioedema 155
null 154
Feto-maternal immune interaction at the placental level 154
The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies 152
null 151
The development of atypical hemolytic uremic syndrome depends on complement C5. 151
Mast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulation 151
Protection against inflammation- and antiphospholipid antibody-caused fetal loss by the chemokine decoy receptor D6 150
Complement production by trophoblast cells at the feto-maternal interface. 150
Cross-talk between the complement system and endothelial cells in physiologic conditions and in vascular diseases. 149
The membrane attack complex of complement induces caspase activation and apoptosis. 147
The endothelium is an extrahepatic site of synthesis of the seventh component of the complement system. 145
Pathophysiological consequences of complement-endothelial cell interaction 141
Complement-endothelial cell interaction: pathophysiological implications. 139
Experimental induction of myelin changes by anti-MAG antibodies and terminal complement complex 139
INTRACEREBROVENTRICULAR INJECTION OF THE TERMINAL COMPLEMENT COMPLEX CAUSES INFLAMMATORY REACTION IN THE RAT BRAIN 138
Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors. 138
Inflammatory response and the endothelium 130
Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. 128
Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium. 123
null 121
null 121
Inhibitory effects of fenofibrate on apoptosis and cell proliferation in human endothelial cells in high glucose 121
null 121
null 119
The terminal complement pathway component: C8 110
Totale 65.527
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.751
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.751
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.188 0 0 73 121 40 132 62 43 146 156 90 325
2022/20231.845 185 248 146 269 142 358 6 158 233 5 70 25
2023/20241.012 65 53 64 33 154 137 153 177 19 15 83 59
2024/202520.722 29 34 137 171 208 245 281 196 356 219 5.897 12.949
2025/202631.785 5.643 4.908 5.655 5.178 5.087 2.347 883 184 730 727 266 177
2026/20271.006 523 300 183 0 0 0 0 0 0 0 0 0
Totale 68.174